Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP386171.RALWiaJFz1NIJha6G3SwuuZkakQXR9dW4Me8dnP0F6b-g130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP386171.RALWiaJFz1NIJha6G3SwuuZkakQXR9dW4Me8dnP0F6b-g130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP386171.RALWiaJFz1NIJha6G3SwuuZkakQXR9dW4Me8dnP0F6b-g130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP386171.RALWiaJFz1NIJha6G3SwuuZkakQXR9dW4Me8dnP0F6b-g130_provenance.
- NP386171.RALWiaJFz1NIJha6G3SwuuZkakQXR9dW4Me8dnP0F6b-g130_assertion description "[Of 74 different genes identified as overexpressed in cancer tissues, several encode proteins with demonstrated clinical diagnostic application, such as alpha-fetoprotein in liver carcinoma, and kallikreins 6 and 10 in ovarian cancer, or therapeutic utility, such as gastrin-releasing peptide/bombesin in lung carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP386171.RALWiaJFz1NIJha6G3SwuuZkakQXR9dW4Me8dnP0F6b-g130_provenance.
- NP386171.RALWiaJFz1NIJha6G3SwuuZkakQXR9dW4Me8dnP0F6b-g130_assertion evidence source_evidence_literature NP386171.RALWiaJFz1NIJha6G3SwuuZkakQXR9dW4Me8dnP0F6b-g130_provenance.
- NP386171.RALWiaJFz1NIJha6G3SwuuZkakQXR9dW4Me8dnP0F6b-g130_assertion SIO_000772 12624183 NP386171.RALWiaJFz1NIJha6G3SwuuZkakQXR9dW4Me8dnP0F6b-g130_provenance.
- NP386171.RALWiaJFz1NIJha6G3SwuuZkakQXR9dW4Me8dnP0F6b-g130_assertion wasDerivedFrom befree-2016 NP386171.RALWiaJFz1NIJha6G3SwuuZkakQXR9dW4Me8dnP0F6b-g130_provenance.
- NP386171.RALWiaJFz1NIJha6G3SwuuZkakQXR9dW4Me8dnP0F6b-g130_assertion wasGeneratedBy ECO_0000203 NP386171.RALWiaJFz1NIJha6G3SwuuZkakQXR9dW4Me8dnP0F6b-g130_provenance.
- befree-2016 importedOn "2016-02-19" NP386171.RALWiaJFz1NIJha6G3SwuuZkakQXR9dW4Me8dnP0F6b-g130_provenance.